Risk capital for Jena-based high-tech company

bm|t beteili­gungs­man­age­ment thürin­gen gmbh invests in Den­tog­nos­tics GmbH.

bm|t has acquired a 28% stake in the Jena-based com­pany as a first step as part of a cap­i­tal increase. For bm|t, this is its tenth invest­ment under­tak­ing in the area of life sci­ences / biotech­nol­ogy. Apart from bm|t, a num­ber of pri­vate investors and tbg Tech­nolo­giebeteili­gungs­ge­sellschaft mbH have also invested in the com­pany. A total of €2.2 mil­lion have been invested in Dentognostics.

Expansion of research and development activities

Den­tog­nos­tics GmbH is using the fresh money to develop its prod­ucts – rapid tests to sup­port the treat­ment and pre­ven­tion of den­tal dis­eases. These include tests to eval­u­ate the risk of caries and tests to mon­i­tor the treat­ment of severe par­o­don­ti­tis or to dis­cover the cause of chronic halitosis.

Den­tog­nos­tics’ rapid tests will be tested from the mid­dle of next year in den­tal surg­eries. The rapid tests can be car­ried out dur­ing treat­ment. Both patient and den­tist will get the results imme­di­ately and the nec­es­sary treat­ment or pre­ven­tive mea­sures can be taken early on and tar­geted appropriately.